Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
1.310
+0.170 (14.91%)
At close: May 12, 2025, 4:00 PM
1.308
-0.002 (-0.12%)
After-hours: May 12, 2025, 4:25 PM EDT
Tango Therapeutics Stock Forecast
TNGX's stock price has decreased by -81.56% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Tango Therapeutics stock have an average target of 12.33, with a low estimate of 8.00 and a high estimate of 19. The average target predicts an increase of 841.22% from the current stock price of 1.31.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Tango Therapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +892.37% | Apr 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Dec 5, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $16 → $8 | Strong Buy | Maintains | $16 → $8 | +510.69% | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +892.37% | Nov 8, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $18 → $8 | Strong Buy | Maintains | $18 → $8 | +510.69% | Nov 7, 2024 |
Financial Forecast
Revenue This Year
29.82M
from 42.07M
Decreased by -29.11%
Revenue Next Year
25.54M
from 29.82M
Decreased by -14.37%
EPS This Year
-1.42
from -1.19
EPS Next Year
-1.44
from -1.42
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 44.2M | 44.2M | 47.6M | ||
| Avg | 29.8M | 25.5M | 28.1M | ||
| Low | 23.5M | n/a | 10.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.0% | 48.1% | 86.2% | ||
| Avg | -29.1% | -14.4% | 10.0% | ||
| Low | -44.1% | - | -57.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.09 | -1.08 | -1.35 | ||
| Avg | -1.42 | -1.44 | -1.63 | ||
| Low | -1.49 | -1.55 | -2.04 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.